We are live on ! Find out more
QTTB icon

Q32 Bio
QTTB

66 hedge funds and large institutions have $640M invested in Q32 Bio in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 13

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

26% more capital invested

Capital invested by funds: $509M → $640M (+$132M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 65 → 66 (+1)

0.05% more ownership

Funds ownership: 3.37% → 3.42% (+0.05%)

Holders
66
Holders Change
+1
Holders Change %
+1.54%
% of All Funds
1.43%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
9
Increased
26
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$3.87M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.74M
3
RI
RTW Investments
New York
+$2.56M
4
MWNA
Marshall Wace North America
New York
+$2.31M
5
BB
BB Biotech
Switzerland
+$2.27M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$6.16M
2
AG
Artal Group
Luxembourg
-$2.24M
3
RSCM
Rock Springs Capital Management
Maryland
-$1.99M
4
BlackRock
BlackRock
New York
-$1.46M
5
Invesco
Invesco
Georgia
-$900K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$145M – – –
Temasek Holdings
2
Temasek Holdings
Singapore
$89.3M – – –
Fidelity Investments
3
Fidelity Investments
Massachusetts
$58.5M -$14.8K -33 -0%
JP Morgan Chase
4
JP Morgan Chase
New York
$54.9M -$6.16M -13,773 -11%
RI
5
RTW Investments
New York
$48.2M +$2.56M +5,734 +6%
BlackRock
6
BlackRock
New York
$38.9M -$1.46M -3,276 -4%
VC
7
Vivo Capital
California
$32.2M – – –
T. Rowe Price Associates
8
T. Rowe Price Associates
Maryland
$29.5M +$2.25M +5,028 +9%
VM
9
VV Manager
Massachusetts
$21.4M – – –
Vanguard Group
10
Vanguard Group
Pennsylvania
$18.3M +$2.74M +6,119 +20%
Franklin Resources
11
Franklin Resources
California
$13.2M +$1.51M +3,378 +15%
Lord, Abbett & Co
12
Lord, Abbett & Co
New Jersey
$12M +$3.87M +8,650 +56%
RSCM
13
Rock Springs Capital Management
Maryland
$10.3M -$1.99M -4,444 -18%
CC
14
Casdin Capital
New York
$9.71M – – –
State Street
15
State Street
Massachusetts
$8.24M +$566K +1,267 +8%
Northern Trust
16
Northern Trust
Illinois
$5.18M +$135K +303 +3%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.67M +$381K +852 +10%
GTP
18
Global Thematic Partners
New York
$4.58M +$759K +1,697 +23%
SFM
19
Sphera Funds Management
Israel
$4.46M – – –
PC
20
Polar Capital
United Kingdom
$2.77M – – –
Ameriprise
21
Ameriprise
Minnesota
$2.73M +$970K +2,171 +66%
MWNA
22
Marshall Wace North America
New York
$2.58M +$2.31M +5,173 New
BB
23
BB Biotech
Switzerland
$2.53M +$2.27M +5,074 New
Victory Capital Management
24
Victory Capital Management
Texas
$2.28M -$106K -237 -5%
Charles Schwab
25
Charles Schwab
California
$1.91M +$58.1K +130 +4%
1
2 3

QTTB Hedge Fund Activity: Q1 2019 in Review

66 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2019, worth a combined $640M — up 26% from $509M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new QTTB positions and 8 closed out — a net gain of 1 holder — while 26 added to existing stakes and 13 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $3.87M. The largest seller was JP Morgan Chase, cutting an estimated $6.16M.

  • 66 institutional investors held Q32 Bio (QTTB) as of Q1 2019, up from 65 in Q4 2018.
  • Funds reported $640M of Q32 Bio stock for Q1 2019, up 26% quarter-over-quarter.
  • 9 funds opened new Q32 Bio positions in Q1 2019 and 8 closed out, a net change of +1 holder.
  • The largest Q32 Bio buyer in Q1 2019 was Lord, Abbett & Co, an estimated $3.87M added.
  • The largest Q32 Bio seller in Q1 2019 was JP Morgan Chase, an estimated $6.16M sold.

Based on aggregated 13F filings for Q1 2019.